AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17964881 — intervention group
Group type: COMPARATOR
Intervention: Between-group comparison at post-radiotherapy assessment
Number of subjects: 21
Study 15166299 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise weight loss (n = 17)
Number of subjects: 54
Study 15166299 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet weight loss (n = 15)
Number of subjects: 54
Study 15166299 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise without weight loss (n = 12)
Number of subjects: 54
Study 15166299 — intervention group
Group type: COMPARATOR
Intervention: Weight-stable control group (n = 10)
Number of subjects: 54
Study 11547642 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracervical prostaglandin E2 gel
Number of subjects: 50
Study 11547642 — intervention group
Group type: COMPARATOR
Intervention: Membrane sweeping
Number of subjects: 50
Study 9676147 — intervention group
Group type: EXPERIMENTAL
Intervention: Karaoke therapy
Number of subjects: 0
Study 9676147 — intervention group
Group type: COMPARATOR
Intervention: Simple singing (Control)
Number of subjects: 0
Study 7741836 — intervention group
Group type: EXPERIMENTAL
Intervention: First visual field tests
Number of subjects: 562
Study 7741836 — intervention group
Group type: EXPERIMENTAL
Intervention: Second visual field tests
Number of subjects: 562
Study 7741836 — intervention group
Group type: EXPERIMENTAL
Intervention: Time interval between tests
Number of subjects: 562
Study 3377923 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancuronium
Number of subjects: 39
Study 3377923 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 39
Study 3377923 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 39
Study 31600271 — intervention group
Group type: EXPERIMENTAL
Intervention: Can do treatment (CDT)
Number of subjects: 158
Study 31600271 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 158
Study 28854538 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine delivered via target-controlled infusion
Number of subjects: 18
Study 28854538 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine in the presence of ambient noise
Number of subjects: 18
Study 28854538 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine in the absence of ambient noise
Number of subjects: 18
Study 25599735 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin, 20 mg/d
Number of subjects: 105
Study 25599735 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin with NER, 500 mg/d
Number of subjects: 105
Study 23917392 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 72
Study 23917392 — intervention group
Group type: COMPARATOR
Intervention: Open resection
Number of subjects: 72
Study 23917392 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (open and laparoscopic)
Number of subjects: 72
Study 21185551 — intervention group
Group type: EXPERIMENTAL
Intervention: Reappraisal
Number of subjects: 73
Study 21185551 — intervention group
Group type: COMPARATOR
Intervention: Suppression
Number of subjects: 73
Study 21185551 — intervention group
Group type: COMPARATOR
Intervention: Acceptance
Number of subjects: 73
Study 18638309 — intervention group
Group type: EXPERIMENTAL
Intervention: Baxter Xenium 170 high‐flux dialyzer (BX)
Number of subjects: 8
Study 18638309 — intervention group
Group type: COMPARATOR
Intervention: Fresenius Optiflux 180 NR (FO)
Number of subjects: 8
Study 18638309 — intervention group
Group type: EXPERIMENTAL
Intervention: Gambro Polyflux 170 H (GP)
Number of subjects: 8
Study 18638309 — intervention group
Group type: COMPARATOR
Intervention: All filters
Number of subjects: 8
Study 16513861 — intervention group
Group type: EXPERIMENTAL
Intervention: Competitive employment
Number of subjects: 1400
Study 16513861 — intervention group
Group type: EXPERIMENTAL
Intervention: Other (noncompetitive) employment
Number of subjects: 1400
Study 16513861 — intervention group
Group type: EXPERIMENTAL
Intervention: No employment activity
Number of subjects: 1400
Study 16513861 — intervention group
Group type: COMPARATOR
Intervention: Access to rehabilitation services
Number of subjects: 1400
Study 12756424 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg nicotine tooth patch (NTP)
Number of subjects: 10
Study 12756424 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg nicotine tooth patch (NTP)
Number of subjects: 10
Study 12756424 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.3 mg nicotine tooth patch (NTP)
Number of subjects: 10
Study 14747959 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentiated thyroid carcinoma patients
Number of subjects: 875
Study 10319446 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually administered mood induction procedure
Number of subjects: 79
Study 10319446 — intervention group
Group type: EXPERIMENTAL
Intervention: Group administered mood induction procedure
Number of subjects: 79
Study 10319446 — intervention group
Group type: COMPARATOR
Intervention: Neutral mood induction
Number of subjects: 79
Study 7604809 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin (40 mg daily)
Number of subjects: 42
Study 7604809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 2224356 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline infiltration prior to mastectomy
Number of subjects: 20
Study 2224356 — intervention group
Group type: COMPARATOR
Intervention: Nothing (control group)
Number of subjects: 20
Study 2224356 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline infiltration
Number of subjects: 20
Study 81586 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised toothbrushing every second week during the school year, using a disclosing solution.
Number of subjects: 200
Study 81586 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 200
Study 31196132 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus clindamycin for 7 days
Number of subjects: 60
Study 31196132 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (flucloxacillin/cefazolin for MSSA; vancomycin/daptomycin for MRSA)
Number of subjects: 60
Study 28327804 — intervention group
Group type: COMPARATOR
Intervention: N-methylglucamine antimoniate (20mg/kg/day for 20 days)
Number of subjects: 101
Study 28327804 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B deoxycholate (1 mg/kg/day for 14 days)
Number of subjects: 101
Study 28327804 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (N-methylglucamine antimoniate and amphotericin B)
Number of subjects: 101
Study 25232714 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative enteral immunonutrition (EIN)
Number of subjects: 37
Study 25232714 — intervention group
Group type: COMPARATOR
Intervention: Standard enteral nutrition (SEN)
Number of subjects: 37
Study 23836966 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education on falls prevention in hospital
Number of subjects: 138
Study 21074752 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT intervention
Number of subjects: 93
Study 21074752 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 93
Study 19179026 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral conjugated estrogen 0.625mg/day
Number of subjects: 132
Study 19179026 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal 300microg/day estradiol hemihidrate
Number of subjects: 132
Study 19179026 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous gel 1.5mg/day estradiol hemihidrate
Number of subjects: 132
Study 19179026 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 132
Study 17370331 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 62
Study 17370331 — intervention group
Group type: COMPARATOR
Intervention: Variceal banding
Number of subjects: 62
Study 15382785 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithia disilicate-based core ceramic for posterior FPDs
Number of subjects: 30
Study 11440787 — intervention group
Group type: EXPERIMENTAL
Intervention: Bretschenider solution (HTK)
Number of subjects: 30
Study 11440787 — intervention group
Group type: COMPARATOR
Intervention: Conventional crystalloid cardioplegia
Number of subjects: 30
Study 9593395 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% MMC for 5 minutes
Number of subjects: 180
Study 9593395 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.04% MMC for 5 minutes
Number of subjects: 180
Study 9593395 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% MMC for 3 minutes
Number of subjects: 180
Study 9593395 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.04% MMC for 3 minutes
Number of subjects: 180
Study 9593395 — intervention group
Group type: COMPARATOR
Intervention: Control with no MMC
Number of subjects: 180
Study 7972649 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation therapy with respiratory feedback (RFB)
Number of subjects: 170
Study 7972649 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 170
Study 7972649 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 170
Study 2656335 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg famotidine twice daily
Number of subjects: 209
Study 2656335 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg famotidine at bedtime
Number of subjects: 209
Study 2656335 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 209
Study 30265016 — intervention group
Group type: EXPERIMENTAL
Intervention: VSST: Veteran‐Supportive Supervisor Training
Number of subjects: 497
Study 30265016 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 497
Study 28600210 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated epirubicin (100 mg/m2 every 2 weeks with 6 mg pegfilgrastim on day 2)
Number of subjects: 4391
Study 28600210 — intervention group
Group type: COMPARATOR
Intervention: Standard epirubicin (100 mg/m2 every 3 weeks)
Number of subjects: 4391
Study 28600210 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine (2500 mg/m2, 1250 mg/m2 given twice daily on days 1-14 of each cycle)
Number of subjects: 4391
Study 28600210 — intervention group
Group type: COMPARATOR
Intervention: CMF (600 mg/m2 cyclophosphamide, 40 mg/m2 methotrexate, 600 mg/m2 fluorouracil)
Number of subjects: 4391
Study 28600210 — intervention group
Group type: COMPARATOR
Intervention: Standard epirubicin
Number of subjects: 4391
Study 28600210 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated epirubicin
Number of subjects: 4391
Study 28600210 — intervention group
Group type: COMPARATOR
Intervention: CMF
Number of subjects: 4391
Study 28600210 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine
Number of subjects: 4391
Study 25499587 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate insertion of Copper T380A IUD
Number of subjects: 68
Study 25499587 — intervention group
Group type: COMPARATOR
Intervention: Delayed insertion of Copper T380A IUD (6 weeks post-cesarean)
Number of subjects: 68
Study 25499587 — intervention group
Group type: EXPERIMENTAL
Intervention: IUD users (both groups)
Number of subjects: 68
Study 25499587 — intervention group
Group type: COMPARATOR
Intervention: Nonusers (both groups)
Number of subjects: 68
Study 24024040 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 0
Study 24024040 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24024040 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 21315637 — intervention group
Group type: EXPERIMENTAL
Intervention: PedsQL 4.0 Generic Core Scales (self-reported)
Number of subjects: 179
Study 21315637 — intervention group
Group type: EXPERIMENTAL
Intervention: PedsQL 4.0 Generic Core Scales (parent proxy-reported)
Number of subjects: 179
Study 21315637 — intervention group
Group type: COMPARATOR
Intervention: PedsQL scores in pediatric patients with ADHD and comorbid psychiatric disorders
Number of subjects: 179
Study 21315637 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD symptom severity
Number of subjects: 179
Study 19625119 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching with supplementary light exposure
Number of subjects: 20
Study 19625119 — intervention group
Group type: COMPARATOR
Intervention: Bleaching without supplementary light exposure
Number of subjects: 20
Study 17893502 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic colectomy
Number of subjects: 872
Study 17893502 — intervention group
Group type: COMPARATOR
Intervention: Open colectomy
Number of subjects: 872
Study 15473195 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-D linear method
Number of subjects: 0
Study 15473195 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-D nonlinear method
Number of subjects: 0
Study 15473195 — intervention group
Group type: COMPARATOR
Intervention: 1-D linear method
Number of subjects: 0
Study 11483171 — intervention group
Group type: EXPERIMENTAL
Intervention: New Zealand pre-readers (English, Roman alphabet)
Number of subjects: 0
Study 11483171 — intervention group
Group type: EXPERIMENTAL
Intervention: Guangzhou reading children (alphabetic Pinyin and logographic Chinese)
Number of subjects: 0
Study 11483171 — intervention group
Group type: COMPARATOR
Intervention: Hong Kong pre-readers (logographic Chinese)
Number of subjects: 0
Study 9786563 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine (30 mg, two capsules)
Number of subjects: 26
Study 9786563 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two identical appearing capsules)
Number of subjects: 26
Study 8156351 — intervention group
Group type: EXPERIMENTAL
Intervention: Levovist 300 mg/ml (10 ml intravenous injection)
Number of subjects: 26
Study 2845188 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (single dose and long term administration)
Number of subjects: 12
Study 2845188 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate
Number of subjects: 12
Study 30919899 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg daily
Number of subjects: 30937
Study 30919899 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg daily
Number of subjects: 30937
Study 30919899 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ramipril and telmisartan
Number of subjects: 30937
Study 30919899 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 30937
Study 27085768 — intervention group
Group type: EXPERIMENTAL
Intervention: Social cognitive theory‐based weight‐management treatments emphasizing physical activity‐derived self‐regulation (n=53)
Number of subjects: 107
Study 27085768 — intervention group
Group type: COMPARATOR
Intervention: Review of a written manual and phone support (n=54)
Number of subjects: 107
Study 25521188 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g SQ-LNS with varying contents of zinc
Number of subjects: 2435
Study 25521188 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispersible tablet containing 0 or 5 mg zinc
Number of subjects: 2435
Study 25521188 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ-LNS
Number of subjects: 2435
Study 25521188 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispersible tablet
Number of subjects: 2435
Study 25521188 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma zinc concentration
Number of subjects: 2435
Study 23764385 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment (mean blood level 0.67 mEq/L)
Number of subjects: 24
Study 21343159 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine 2% (1.5 mg kg(‐1) bolus at induction followed by 2.0 mg kg(‐1) h(‐1) infusion)
Number of subjects: 99
Study 17609296 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (200 mg every 2 weeks by intramuscular injection with placebo pill daily)
Number of subjects: 69
Study 17609296 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone plus Finasteride (200 mg of T every 2 weeks by intramuscular injection with 5 mg of finasteride daily)
Number of subjects: 69
Study 17609296 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo injections and pills)
Number of subjects: 69
Study 15728645 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute insulin-glucose infusion followed by insulin-based long-term glucose control (Group 1)
Number of subjects: 1253
Study 15728645 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-glucose infusion followed by standard glucose control (Group 2)
Number of subjects: 1253
Study 15728645 — intervention group
Group type: COMPARATOR
Intervention: Routine metabolic management according to local practice (Group 3)
Number of subjects: 1253
Study 15728645 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (1-3 combined)
Number of subjects: 1253
Study 15728645 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (1-3)
Number of subjects: 1253
Study 12480479 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-made 'language' using gestures in communicative contexts
Number of subjects: 0
Study 12480479 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-communicative context using pictures for reconstruction
Number of subjects: 0
Study 9790158 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg/day
Number of subjects: 36
Study 9790158 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 8547097 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant factor VIII (r-VIII SQ, Pharmacia, Sweden)
Number of subjects: 12
Study 8547097 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 12
Study 2696506 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% plus fentanyl 75 mcg
Number of subjects: 14
Study 2696506 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.5%
Number of subjects: 14
Study 1104246 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine gluconate solution, twice a day
Number of subjects: 54
Study 1104246 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% chlorhexidine solution
Number of subjects: 54
Study 1104246 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthrinse
Number of subjects: 54
Study 30195275 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon catheter sinuplasty (BCS) added to adenoidectomy with maxillary sinus irrigation
Number of subjects: 25
Study 30195275 — intervention group
Group type: COMPARATOR
Intervention: Adenoidectomy with maxillary sinus irrigation alone (Control)
Number of subjects: 25
Study 27595811 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief motivational intervention to reduce risky alcohol use during hospitalization
Number of subjects: 141
Study 23850885 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope video laryngoscopy (GVL)
Number of subjects: 20
Study 23850885 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy (DL)
Number of subjects: 20
Study 23850885 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope video laryngoscopy with bougie (GVL-B)
Number of subjects: 20
Study 23850885 — intervention group
Group type: COMPARATOR
Intervention: Comparison of GVL to DL
Number of subjects: 20
Study 23850885 — intervention group
Group type: COMPARATOR
Intervention: Comparison of GVL-B to DL
Number of subjects: 20
Study 21838784 — intervention group
Group type: EXPERIMENTAL
Intervention: gemfibrozil 600 mg
Number of subjects: 11
Study 21838784 — intervention group
Group type: EXPERIMENTAL
Intervention: itraconazole 100 mg
Number of subjects: 11
Study 21838784 — intervention group
Group type: EXPERIMENTAL
Intervention: gemfibrozil-itraconazole combination
Number of subjects: 11
Study 21838784 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 11
Study 20578781 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine plus oral antidiabetes drugs (OADs)
Number of subjects: 0
Study 20578781 — intervention group
Group type: COMPARATOR
Intervention: Premixed insulin only
Number of subjects: 0
Study 18395908 — intervention group
Group type: EXPERIMENTAL
Intervention: Prometheus liver assist system (n = 8)
Number of subjects: 24
Study 18395908 — intervention group
Group type: COMPARATOR
Intervention: Molecular Adsorbent Recirculation System (MARS) (Control group 1, n = 8)
Number of subjects: 24
Study 18395908 — intervention group
Group type: COMPARATOR
Intervention: Hemodialysis (Control group 2, n = 8)
Number of subjects: 24
Study 16087029 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone inner ear perfusion (4 mg/mL)
Number of subjects: 22
Study 16087029 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 22
Study 12600856 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (10 mg Fe, 5 d/wk for 6 mo)
Number of subjects: 387
Study 12600856 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg Zn, 5 d/wk for 6 mo)
Number of subjects: 387
Study 12600856 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (2.4 mg beta-carotene, 5 d/wk for 6 mo)
Number of subjects: 387
Study 12600856 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron + Zinc supplementation (10 mg each, 5 d/wk for 6 mo)
Number of subjects: 387
Study 12600856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 387
Study 11214351 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A, 3 mg retinol equivalent/day
Number of subjects: 697
Study 11214351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 697
Study 8626351 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate (given twice daily)
Number of subjects: 16
Study 8626351 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium (added on Days 6-10)
Number of subjects: 16
Study 8626351 — intervention group
Group type: COMPARATOR
Intervention: Placebo (given twice daily)
Number of subjects: 16
Study 1601510 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyamide (PAM)
Number of subjects: 10
Study 1601510 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyacrylonitrile (AN69)
Number of subjects: 10
Study 1601510 — intervention group
Group type: EXPERIMENTAL
Intervention: Both membranes
Number of subjects: 10
Study 6429875 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 32
Study 6429875 — intervention group
Group type: COMPARATOR
Intervention: Conventional Oral Nutritional Support (CN)
Number of subjects: 32